000 01275 a2200337 4500
005 20250513203528.0
264 0 _c20000321
008 200003s 0 0 eng d
022 _a0301-0082
024 7 _a10.1016/s0301-0082(99)00032-5
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAlexi, T
245 0 0 _aNeuroprotective strategies for basal ganglia degeneration: Parkinson's and Huntington's diseases.
_h[electronic resource]
260 _bProgress in neurobiology
_cApr 2000
300 _a409-70 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.; Review
650 0 4 _aAnimals
650 0 4 _aBasal Ganglia
_xdrug effects
650 0 4 _aHumans
650 0 4 _aHuntington Disease
_xdrug therapy
650 0 4 _aNeuroprotective Agents
_xpharmacology
650 0 4 _aParkinson Disease
_xdrug therapy
700 1 _aBorlongan, C V
700 1 _aFaull, R L
700 1 _aWilliams, C E
700 1 _aClark, R G
700 1 _aGluckman, P D
700 1 _aHughes, P E
773 0 _tProgress in neurobiology
_gvol. 60
_gno. 5
_gp. 409-70
856 4 0 _uhttps://doi.org/10.1016/s0301-0082(99)00032-5
_zAvailable from publisher's website
999 _c10651191
_d10651191